Skip to content

Database of Patients Treated With Respiratory Support

Observatoire de l'ANTADIR - Database of Patients Registered as Treated With Respiratory Support in a Multicenter Homecare Federation for Patients Wirh Respiratory Problems

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01181869
Acronym
observatory
Enrollment
120000
Registered
2010-08-13
Start date
1983-01-31
Completion date
2015-01-31
Last updated
2012-04-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Respiratory Failure

Keywords

respiratory failure, oxygen, sleep apnoea, ventilation

Brief summary

An observatory of patients registered in 22 local homecare associations in France, for respiratory diseases, with annual data update. Demographic and clinical data are registered rendering possible extraction of clinical and prognostic data.

Detailed description

Patients on treatment for respiratory failure and for sleep apnoea are registered on entry into treatment with recording of clincal and demographic data. Data available on age, sex, region, respiratoy function, blood gases, smoking status and some bilogical data

Interventions

DEVICEoxygen

oxygen therapy, ventilation for respiratory failure CPAP for sleep apnoea

Sponsors

Association Nationale pour les Traitements A Domicile, les Innovations et la Recherche
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* requiring respiratory support

Design outcomes

Primary

MeasureTime frameDescription
death20 yearslong term follow up of a regularly updated database

Secondary

MeasureTime frameDescription
treatment adjustment20 yearsChange of treatment from oxygen to ventilatioion or other evolution

Countries

France

Contacts

Primary ContactLine Mounier, MSc
antadir@antadir.com0033156814060
Backup ContactDan Veale, MD
veale.dan@gmail.com0033156814060

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026